TCR2 Therapeutics Inc.
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Abstract:

Provided herein are recombinant nucleic acids encoding T cell receptor (TCR) fusion proteins (TFPs) and a TCR constant domain, modified T cells expressing the encoded molecules, and methods of use thereof for the treatment of diseases, including cancer.